Geneva Advisors’s Praxair Inc PX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
$1.57M Sell
11,817
-275
-2% -$35.3K 0.03% 275
2017
Q1
$1.43M Sell
12,092
-1,281
-10% -$151K 0.03% 279
2016
Q4
$1.57M Buy
13,373
+822
+7% +$97.7K 0.03% 246
2016
Q3
$1.52M Hold
12,551
0.03% 243
2016
Q2
$1.41M Sell
12,551
-100
-0.8% -$11.3K 0.03% 245
2016
Q1
$1.45M Buy
12,651
+29
+0.2% +$3.03K 0.03% 235
2015
Q4
$1.29M Sell
12,622
-266
-2% -$29K 0.02% 261
2015
Q3
$1.31M Buy
12,888
+3,239
+34% +$357K 0.03% 254
2015
Q2
$1.15M Buy
9,649
+5,483
+132% +$668K 0.02% 283
2015
Q1
$503K Sell
4,166
-306
-7% -$38.3K 0.01% 415
2014
Q4
$579K Sell
4,472
-879
-16% -$111K 0.01% 383
2014
Q3
$690K Buy
5,351
+283
+6% +$37.1K 0.01% 372
2014
Q2
$673K Sell
5,068
-142,103
-97% -$18.6M 0.01% 385
2014
Q1
$19.3M Buy
147,171
+4,260
+3% +$552K 0.35% 81
2013
Q4
$18.6M Buy
142,911
+7,281
+5% +$908K 0.34% 79
2013
Q3
$16.3M Sell
135,630
-442
-0.3% -$52.5K 0.34% 83
2013
Q2
$15.7M Buy
+136,072
New +$15.5M 0.36% 79

Other funds holding PX

Geneva Advisors's PX Position: Q2 2017 in Review

Geneva Advisors reduced its Praxair Inc (PX) stake by 2.3% in Q2 2017, selling an estimated $35.3K and leaving 11,817 shares worth $1.57M. The position accounts for 0.03% of the portfolio, ranked #275.

Geneva Advisors first reported a position in PX in Q2 2013 and has held it in 17 quarters since. The position peaked at $19.3M in Q1 2014. 922 funds tracked by Wall St. Rank hold PX as of Q2 2017.

  • Geneva Advisors held 11,817 shares of Praxair Inc worth $1.57M as of Q2 2017.
  • Geneva Advisors sold 275 Praxair Inc shares in Q2 2017, an estimated $35.3K.
  • Praxair Inc made up 0.03% of Geneva Advisors's portfolio in Q2 2017, its #275 holding.
  • Geneva Advisors first reported a position in Praxair Inc in Q2 2013 and has held it in 17 quarters since.
  • Geneva Advisors's Praxair Inc position peaked at $19.3M in Q1 2014.
  • 922 funds tracked by Wall St. Rank held Praxair Inc as of Q2 2017.

Based on Geneva Advisors's 13F filing for Q2 2017, filed 7 Aug 2017.